Opioid epidemic

Medicare for All's missing mental health discussion

Illustration of a health plus on a therapist couch.
Illustration: Aïda Amer/Axios

America's mental health care system is in dire need of an overhaul, but the any real specifics are largely missing from the 2020 debate about health care.

Why it matters: Suicide and drug overdose rates continue to rise, and the U.S. faces a shortage of mental health providers and a lack of access to treatment.

AP: China's hidden, growing opioid crisis

In this image, small round white oxycodone pills spill out of a prescription bottle
Oxycodone, an addictive narcotic pain reliever. Photo: Education Images/Universal Images Group via Getty Images

A lack of treatment options, overprescription and little official understanding of the scale of painkiller abuse in China are likely contributing to the spread of opioid addiction in the country, per AP analyses.

What's happening: Drug company Mundipharma has "pushed ever larger doses" of painkillers like OxyContin in China, "even as it became clear that higher doses present higher risks," AP found in November. Mundipharma is owned by the Sackler family, which also owns Purdue Pharma, the OxyContin maker accused of helping fuel the U.S. opioid crisis.